Kreuter J
Institut für Pharmazeutische Technologie, J.W. Goethe-Universität, Frankfurt/Main, Germany.
J Anat. 1996 Dec;189 ( Pt 3)(Pt 3):503-5.
Nanoparticles are polymeric particles in the nanometer size range whereas microparticles are particles in the micrometre size range. Both types of particle are used as drug carriers into which drugs or antigens may be incorporated in the form of solid solutions or solid dispersions or onto which these materials may be absorbed or chemically bound. These particles have been shown to enhance the delivery of certain drugs across a number of natural and artificial membranes. In addition, the particles were shown to accumulate in areas of the intestine that appear to be the Peyer's patches. Possibly because of the combination of both effects these particles were able to significantly improve the bioavailability of some drugs after peroral administration in comparison with solutions. Recently nanoparticles coated with polysorbate 80 enabled the passage of small peptides and other drugs across the blood-brain barrier and the exhibition of a pharmacological effect after intravenous injection. Without the use of this type of nanoparticles the drugs did not cross this barrier and yielded no effect.
纳米颗粒是纳米尺寸范围内的聚合物颗粒,而微粒是微米尺寸范围内的颗粒。这两种类型的颗粒都用作药物载体,药物或抗原可以以固溶体或固体分散体的形式掺入其中,或者这些材料可以吸附或化学结合在其上。这些颗粒已被证明能增强某些药物穿过多种天然和人工膜的递送。此外,这些颗粒在肠道中似乎是派尔集合淋巴结的区域积累。可能由于这两种作用的结合,与溶液相比,这些颗粒在口服给药后能够显著提高某些药物的生物利用度。最近,涂有聚山梨酯80的纳米颗粒能够使小肽和其他药物穿过血脑屏障,并在静脉注射后发挥药理作用。如果不使用这种类型的纳米颗粒,药物就无法穿过这道屏障,也不会产生效果。